02-02-2022, 02:43 PM
Pfizer reports earnings Before Market Open Feb 8th ( I will be following this earnings call closely).
Earnings Expectations -In the last reported quarter, the company beat earnings expectations by 24.07%
The company has a four-quarter earnings surprise of 10.85%, on average.
Q1 2021 - Beat by 0.16
Q2 2021 - Beat by 0.10
Q3 2021 - Beat by 0.25
Q4 2021 - Reports Feb 8th
Pfizer vs Industry -
EPS (TTM) Pfizer 3.32 Industry 3.36
P/E (TTM) Pfizer 15.98 Industry 34.36
P/E (5-Year Avg) Pfizer 19.26 Industry 39.35
EPS Growth (TTM vs Prior TTM) Pfizer +232.00% Industry -91.67%
EPS Growth (last Qtr vs same Qtr prior year) Pfizer +787.50% Industry +125.65%
In the news -
In December, Pfizer announced an agreement to acquire Arena pharmaceuticals for $100 per share or $6.7 billion in an all-cash deal.
On Feb 1st, Pfizer along with partner BioNTech requested emergency Authorization use for their two-dose Covid-19 vaccine for children age 6 months up to 5 years.
Earnings Expectations -In the last reported quarter, the company beat earnings expectations by 24.07%
The company has a four-quarter earnings surprise of 10.85%, on average.
Q1 2021 - Beat by 0.16
Q2 2021 - Beat by 0.10
Q3 2021 - Beat by 0.25
Q4 2021 - Reports Feb 8th
Pfizer vs Industry -
EPS (TTM) Pfizer 3.32 Industry 3.36
P/E (TTM) Pfizer 15.98 Industry 34.36
P/E (5-Year Avg) Pfizer 19.26 Industry 39.35
EPS Growth (TTM vs Prior TTM) Pfizer +232.00% Industry -91.67%
EPS Growth (last Qtr vs same Qtr prior year) Pfizer +787.50% Industry +125.65%
In the news -
In December, Pfizer announced an agreement to acquire Arena pharmaceuticals for $100 per share or $6.7 billion in an all-cash deal.
On Feb 1st, Pfizer along with partner BioNTech requested emergency Authorization use for their two-dose Covid-19 vaccine for children age 6 months up to 5 years.